AGP Executive Report
Last update: 4 hours agoFDA & HIV Care: Dolutegravir (Tivicay PD) won FDA approval for newborns with HIV under 4 weeks old and at least 2 kg, expanding early treatment options. Pulmonary Fibrosis Research: Boston University scientists identified a distinct lung-vein cell population that activates after injury and helps drive scarring, pointing to new therapy targets. Maternal Mental Health & Justice: In Massachusetts’ Lindsay Clancy trial, jurors continued deliberations with no verdict yet; her lawyer said she’s “nervous and scared,” while the case keeps spotlighting postpartum psychosis and how mental illness is treated and understood. Cancer Breakthrough: The FDA approved daraxonrasib (Rasonque), the first drug shown to substantially extend survival in advanced pancreatic cancer. Public Health & Food Safety: A large frozen Buffalo chicken recall was issued after products were produced without federal inspection; separately, the lettuce-linked Cyclospora outbreak added more states as case counts climbed. Substance Policy: Massachusetts’ kratom ban took effect as retailers sued the state. Local Care Access: The Brattleboro VA clinic in Vermont is set to resume normal operations after repairs, with care rerouted during closure.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
